Methods for the treatment of rheumatoid arthritis
US9943594B2 · kind B2 · utility
6Cited by
10References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 10, 2012 |
| Grant date | Apr 17, 2018 |
| Priority date | — |
| Expiry date | Jul 28, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/545
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compositions and methods of treating and improving the symptoms of rheumatoid arthritis using an antibody or antigen-binding fragment thereof that specifically binds human interleukin-6 receptor (hIL-6R).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.